Jan C Wiemer

Title: Jan C Wiemer: Innovator in Toxicological Assessments

Introduction

Jan C Wiemer is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of toxicological assessments, particularly in the diagnosis and treatment of conditions related to peroxisomal proliferation and liver enzyme induction. With a total of eight patents to his name, Wiemer has established himself as a key figure in his area of expertise.

Latest Patents

Wiemer's latest patents include innovative methods for assessing increased peroxisomal proliferation. This invention focuses on toxicological assessments for risk stratification of chemical compounds. It provides a method for diagnosing increased peroxisomal proliferation and determining whether a compound can induce such proliferation in a subject. Additionally, it includes a data collection of characteristic values of metabolites and a system for diagnosing this condition. Another significant patent addresses methods related to liver enzyme induction as a predisposition for liver toxicity. This invention also pertains to diagnosing the pro-pathological effects of compounds that induce liver enzymes, along with a data collection and diagnostic device for this purpose.

Career Highlights

Throughout his career, Jan C Wiemer has worked with notable companies such as Metanomics GmbH and BASF SE Corporation. His work has focused on developing methods and systems that enhance the understanding of toxicological effects and improve diagnostic capabilities in the medical field.

Collaborations

Wiemer has collaborated with esteemed colleagues, including Edgar Leibold and Tilmann B Walk. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jan C Wiemer is a distinguished inventor whose work in toxicological assessments has led to significant advancements in the diagnosis and treatment of chemical compound effects. His innovative patents and collaborations highlight his commitment to improving health outcomes through scientific research.